ASBP
Price
$8.78
Change
+$0.66 (+8.13%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
11.92M
Intraday BUY SELL Signals
ENGN
Price
$1.93
Change
-$0.05 (-2.53%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
132.02M
82 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASBP vs ENGN

ASBP vs ENGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ASBP vs. ENGN commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a StrongBuy and ENGN is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ASBPENGN
RSI
ODDS (%)
Bearish Trend 2 days ago
29%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
35%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
52%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 18 days ago
80%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
31%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (ASBP: $8.12 vs. ENGN: $1.98)
Brand notoriety: ASBP and ENGN are both not notable
ASBP represents the Auto Parts: OEM, while ENGN is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 41% vs. ENGN: 104%
Market capitalization -- ASBP: $11.92M vs. ENGN: $132.02M
ASBP [@Auto Parts: OEM] is valued at $11.92M. ENGN’s [@Biotechnology] market capitalization is $132.02M. The market cap for tickers in the [@Auto Parts: OEM] industry ranges from $1.93K to $69.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Auto Parts: OEM] industry is $4.89B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green while ENGN’s FA Score has 1 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • ENGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ASBP and ENGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASBP’s TA Score shows that 3 TA indicator(s) are bullish while ENGN’s TA Score has 6 bullish TA indicator(s).

  • ASBP’s TA Score: 3 bullish, 5 bearish.
  • ENGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ENGN is a better buy in the short-term than ASBP.

Price Growth

ASBP (@Auto Parts: OEM) experienced а -6.67% price change this week, while ENGN (@Biotechnology) price change was +3.13% for the same time period.

The average weekly price growth across all stocks in the @Auto Parts: OEM industry was -1.19%. For the same industry, the average monthly price growth was -5.25%, and the average quarterly price growth was -4.45%.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

ENGN is expected to report earnings on Dec 23, 2026.

Industries' Descriptions

@Auto Parts: OEM (-1.19% weekly)

OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ASBP
Daily Signal:
Gain/Loss:
ENGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEF81.561.97
+2.48%
Greif
TBPH17.03N/A
N/A
Theravance Biopharma
DFDV5.37N/A
N/A
DeFi Development Corp
SLF77.67-0.30
-0.38%
Sun Life Financial
XHLD0.55-0.10
-14.87%
TEN Holdings Inc.

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
-2.75%
SPRO - ASBP
42%
Loosely correlated
+4.13%
ALZN - ASBP
38%
Loosely correlated
-23.12%
DCOY - ASBP
31%
Poorly correlated
-5.84%
CMPX - ASBP
28%
Poorly correlated
-13.36%
INTS - ASBP
27%
Poorly correlated
-4.75%
More

ENGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENGN has been closely correlated with TRDA. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if ENGN jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENGN
1D Price
Change %
ENGN100%
-1.00%
TRDA - ENGN
78%
Closely correlated
-10.55%
COGT - ENGN
48%
Loosely correlated
-1.34%
PHAR - ENGN
43%
Loosely correlated
-0.40%
INSM - ENGN
42%
Loosely correlated
-4.86%
ASBP - ENGN
36%
Loosely correlated
-2.75%
More